Deere, Amgen, Copart And More: CNBC's 'Final Trades'

On CNBC's “Halftime Report Final Trades,” Jim Lebenthal of Cerity Partners named Deere & Company DE as his final trade.

On Wednesday, Citigroup analyst Kyle Menges maintained Deere with a Neutral and raised the price target from $395 to $420.

Jason Snipe of Odyssey Capital Advisors said Amgen Inc. AMGN has got a really strong pipeline.

On Monday, Barclays analyst Carter Gould maintained Amgen with an Equal-Weight rating and raised the price target from $300 to $315.

Don't forget to check out our premarket coverage here

Shannon Saccocia of NB Private Wealth named iShares U.S. Healthcare ETF IYH.

Joseph M. Terranova of Virtus Investment Partners picked Copart, Inc. CPRT, an industrial name.

On Sept. 4, Copart reported quarterly earnings of 33 cents per share, which missed the analyst consensus estimate by 8.33%. Quarterly revenue came in at $1.068 billion, which missed the analyst consensus estimate of $1.081 billion. Gross profit and net income were $454 million and $323 million, respectively.

Price Action:

• Deere gained 1.3% to close at $405.48 during Wednesday's session.
• Amgen shares gained 1.5% to close at $322.41 on Wednesday.
• iShares U.S. Healthcare ETF gained 1% during Wednesday's session.
• Copart shares gained 2.6% to settle at $55.84 on Wednesday.

Check This Out:

• S&P Settles At Record High As Apple, Amazon Shares Surge: Investor Optimism Improves Ahead Of Inflation Data

Image: Shutterstock